296 established journals publish at least 20 % of their articles in Infectious Diseases. 204 of them are fully open access. Where open-access journals charge a fee, the median is 2 353 USD. Highest recent citation rates: Signal Transduction and Targeted Therapy, MMWR Morbidity and Mortality Weekly Report, EClinicalMedicine.
296 journals
Most relevant first: how much of a journal's work is in Infectious Diseases, how many articles it publishes and how often they are cited. Click a column to sort.
| The Lancet Infectious DiseasesElsevier BV | 38 % | 559 | 12.09 | 373 | Subscription; open access option 7 280 USD |
| EClinicalMedicineElsevier BV | 35 % | 593 | 12.38 | 150 | 5 780 USD |
| The Lancet HIVElsevier BV | 51 % | 177 | 5.79 | 121 | Subscription; open access option 7 280 USD |
| The Lancet MicrobeElsevier BV | 39 % | 228 | 11.83 | 88 | 7 280 USD |
| Signal Transduction and Targeted TherapySpringer Nature | 22 % | 422 | 49.97 | 286 | 3 790 USD |
| Journal of the International AIDS SocietyInternational AIDS Society | 50 % | 203 | 3.56 | 116 | 2 600 USD |
| Clinical Infectious DiseasesOxford University Press | 33 % | 856 | 5.96 | 483 | Subscription; open access option 4 763 USD |
| BMC Infectious DiseasesBioMed Central | 37 % | 1 338 | 3.16 | 175 | 3 090 USD |
| Emerging Microbes & InfectionsTaylor & Francis | 36 % | 264 | 7.48 | 131 | 2 643 USD |
| Journal of Infection and Public HealthElsevier BV | 42 % | 303 | 3.92 | 100 | 2 310 USD |
| MMWR Morbidity and Mortality Weekly ReportCenters for Disease Control and Prevention | 26 % | 281 | 19.68 | 251 | Open access, fee unknown |
| Journal of Hospital InfectionElsevier BV | 42 % | 303 | 2.81 | 175 | Subscription; open access option 4 000 USD |
| JAIDS Journal of Acquired Immune Deficiency SyndromesLippincott Williams & Wilkins | 46 % | 242 | 2.52 | 192 | Subscription |
| International Journal of Infectious DiseasesElsevier BV | 37 % | 814 | 2.58 | 170 | 2 900 USD |
| Journal of InfectionElsevier BV | 30 % | 344 | 7.04 | 174 | 4 030 USD |
| VirusesMultidisciplinary Digital Publishing Institute | 26 % | 2 309 | 4.57 | 186 | 3 137 USD |
| Emerging infectious diseasesCenters for Disease Control and Prevention | 29 % | 517 | 6.21 | 326 | Open access, fee unknown |
| HIV MedicineWiley | 48 % | 187 | 2.08 | 102 | Subscription; open access option 4 150 USD |
| AIDSLippincott Williams & Wilkins | 43 % | 334 | 2.07 | 268 | Subscription |
| EBioMedicineElsevier BV | 23 % | 573 | 10.59 | 180 | 5 780 USD |
| Infection Control and Hospital EpidemiologyCambridge University Press | 46 % | 336 | 1.68 | 195 | Subscription; open access option 3 550 USD |
| AIDS and BehaviorSpringer Science+Business Media | 38 % | 373 | 2.38 | 159 | Subscription; open access option 4 590 USD |
| Infectious Diseases and TherapyAdis, Springer Healthcare | 33 % | 179 | 5.33 | 75 | 7 400 USD |
| AIDS Research and TherapyBioMed Central | 49 % | 101 | 2.32 | 67 | 2 990 USD |
| AIDS Patient Care and STDsMary Ann Liebert, Inc. | 47 % | 66 | 3.20 | 118 | Subscription |
| Journal of Medical VirologyWiley | 28 % | 805 | 3.50 | 196 | Subscription; open access option 4 730 USD |
| VaccinesMultidisciplinary Digital Publishing Institute | 22 % | 1 661 | 4.50 | 134 | 3 258 USD |
| American Journal of Infection ControlElsevier BV | 44 % | 445 | 1.27 | 170 | Subscription; open access option 3 360 USD |
| Current Opinion in HIV and AIDSLippincott Williams & Wilkins | 43 % | 62 | 3.49 | 98 | Subscription |
| Current HIV/AIDS ReportsSpringer Science+Business Media | 40 % | 46 | 5.51 | 96 | Subscription; open access option 4 190 USD |
| IJID RegionsElsevier BV | 41 % | 163 | 2.22 | 24 | 1 380 USD |
| HIV/AIDS - Research and Palliative CareDove Medical Press | 49 % | 61 | 2.40 | 43 | 2 320 USD |
| Antimicrobial Resistance and Infection ControlBioMed Central | 30 % | 170 | 4.93 | 104 | 3 290 USD |
| Infectious Disease ReportsMultidisciplinary Digital Publishing Institute | 39 % | 105 | 3.03 | 43 | 2 172 USD |
| Open Forum Infectious DiseasesOxford University Press | 34 % | 2 444 | 1.21 | 102 | 4 053 USD |
| Clinical Microbiology and InfectionElsevier BV | 26 % | 386 | 4.69 | 250 | Subscription; open access option 3 780 USD |
| Biosafety and HealthElsevier BV | 44 % | 50 | 3.51 | 29 | 2 500 USD |
| PLoS MedicinePublic Library of Science | 24 % | 220 | 8.43 | 350 | 6 460 USD |
| Microbiology SpectrumAmerican Society for Microbiology | 22 % | 1 554 | 3.91 | 136 | 2 500 USD |
| Journal of Epidemiology and Global HealthElsevier BV | 32 % | 101 | 4.88 | 58 | 2 690 USD |
| npj VaccinesNature Portfolio | 24 % | 216 | 6.97 | 79 | 3 890 USD |
| Expert Review of Anti-infective TherapyTaylor & Francis | 32 % | 106 | 4.09 | 125 | Subscription |
| Southern African Journal of HIV MedicineAOSIS | 53 % | 41 | 1.88 | 36 | 605 USD |
| Therapeutic Advances in Infectious DiseaseSAGE Publishing | 39 % | 92 | 2.49 | 44 | 2 800 USD |
| Journal of Microbiology Immunology and InfectionElsevier BV | 33 % | 127 | 3.33 | 87 | 2 000 USD |
| MycosesWiley | 30 % | 157 | 4.01 | 113 | Subscription; open access option 4 780 USD |
| TuberculosisElsevier BV | 38 % | 96 | 2.47 | 110 | Subscription; open access option 2 690 USD |
| EurosurveillanceEuropean Centre for Disease Prevention and Control | 22 % | 252 | 8.05 | 173 | Open access, fee unknown |
| The Lancet Regional Health - EuropeElsevier BV | 20 % | 294 | 8.78 | 88 | 4 930 USD |
| Tropical Medicine and Infectious DiseaseMultidisciplinary Digital Publishing Institute | 26 % | 371 | 3.42 | 68 | 3 258 USD |
| Infectious Diseases of PovertyBioMed Central | 26 % | 122 | 6.70 | 93 | 2 690 USD |
| Medical MycologyOxford University Press | 27 % | 224 | 3.92 | 136 | Subscription; open access option 4 889 USD |
| Reviews in Medical VirologyWiley | 28 % | 103 | 5.14 | 131 | Subscription; open access option 4 880 USD |
| AIDS CareTaylor & Francis | 41 % | 204 | 1.32 | 136 | Subscription |
| Infezioni in MedicinaPublisher unknown | 41 % | 60 | 2.49 | 21 | Subscription |
| Communications MedicineNature Portfolio | 22 % | 260 | 6.07 | 55 | 3 690 USD |
| PLoS neglected tropical diseasesPublic Library of Science | 21 % | 843 | 4.05 | 217 | 2 670 USD |
| PLOS Global Public HealthPublic Library of Science | 22 % | 818 | 3.33 | 51 | 2 496 USD |
| The International Journal of Tuberculosis and Lung DiseaseInternational Union Against Tuberculosis and Lung Disease | 40 % | 182 | 1.44 | 89 | Subscription |
| Infection Prevention in PracticeElsevier BV | 39 % | 72 | 2.34 | 27 | 1 500 USD |
| The Lancet Regional Health - AmericasElsevier BV | 24 % | 260 | 4.29 | 61 | 4 930 USD |
| IJTLD OPENPublisher unknown | 42 % | 46 | 2.55 | 12 | Open access, fee unknown |
| Journal of Clinical Tuberculosis and Other Mycobacterial DiseasesElsevier BV | 38 % | 72 | 2.44 | 38 | 2 470 USD |
| Infectious Diseases & ImmunityWolters Kluwer | 47 % | 40 | 2.02 | 11 | Open access, fee unknown |
| The Journal of Infectious DiseasesOxford University Press | 21 % | 610 | 4.10 | 369 | Subscription; open access option 4 763 USD |
| Infectious MedicineElsevier BV | 38 % | 36 | 3.74 | 19 | 2 500 USD |
| World Journal of VirologyPublisher unknown | 40 % | 42 | 2.94 | 37 | Open access, fee unknown |
| Journal of Antimicrobial ChemotherapyOxford University Press | 21 % | 469 | 4.31 | 266 | Subscription; open access option 3 784 USD |
| Antimicrobial Agents and ChemotherapyAmerican Society for Microbiology | 20 % | 473 | 4.46 | 357 | Open access, fee unknown |
| MedElsevier BV | 20 % | 137 | 9.19 | 67 | Subscription; open access option 9 350 USD |
| Frontiers in VirologyFrontiers Media | 37 % | 58 | 2.47 | 20 | 2 353 USD |
| Journal of Clinical Virology PlusElsevier BV | 57 % | 45 | 1.03 | 13 | 2 320 USD |
| Infection and Drug ResistanceDove Medical Press | 22 % | 631 | 2.85 | 95 | 2 836 USD |
| China CDC WeeklyPublisher unknown | 27 % | 213 | 2.69 | 39 | Open access, fee unknown |
| npj VirusesSpringer Science+Business Media | 33 % | 33 | 5.31 | 17 | 2 790 USD |
| Journal of the International Association of Providers of AIDS Care (JIAPAC)SAGE Publishing | 46 % | 51 | 1.45 | 38 | 2 000 USD |
| Health Science ReportsWiley | 22 % | 744 | 2.59 | 46 | 3 280 USD |
| Antiviral ResearchElsevier BV | 23 % | 184 | 4.29 | 178 | Subscription; open access option 4 160 USD |
| Infectious Diseases NowElsevier BV | 28 % | 176 | 2.33 | 28 | Subscription; open access option 1 640 USD |
| DiseasesMultidisciplinary Digital Publishing Institute | 22 % | 232 | 4.00 | 65 | 2 172 USD |
| The Journal of Infection in Developing CountriesOpen Learning on Enteric Pathogens | 29 % | 271 | 1.68 | 84 | 394 USD |
| AIDS Research and Human RetrovirusesMary Ann Liebert, Inc. | 40 % | 94 | 1.35 | 127 | Subscription |
| Infectious Disorders - Drug TargetsBentham Science Publishers | 41 % | 86 | 1.32 | 58 | Subscription |
| Food and Environmental VirologySpringer Science+Business Media | 32 % | 44 | 3.36 | 58 | Subscription; open access option 2 990 USD |
| Indian Journal of TuberculosisElsevier BV | 41 % | 134 | 0.98 | 36 | Subscription |
| COVIDPublisher unknown | 39 % | 135 | 1.10 | 19 | 1 207 USD |
| International Journal of STD & AIDSSAGE Publishing | 29 % | 170 | 1.84 | 96 | Subscription; open access option 4 150 USD |
| Journal of Korean Medical ScienceKorean Academy of Medical Sciences | 21 % | 365 | 3.02 | 111 | 690 USD |
| HIV Research & Clinical PracticeTaylor & Francis | 46 % | 23 | 1.92 | 15 | Open access, fee unknown |
| Journal of Clinical VirologyElsevier BV | 23 % | 136 | 3.41 | 150 | Subscription; open access option 4 210 USD |
| Journal of the Association of Nurses in AIDS CareLippincott Williams & Wilkins | 46 % | 77 | 0.90 | 71 | Subscription |
| Travel Medicine and Infectious DiseaseElsevier BV | 21 % | 175 | 3.90 | 96 | 3 710 USD |
| Current Opinion in Infectious DiseasesLippincott Williams & Wilkins | 24 % | 88 | 3.64 | 140 | Subscription |
| Pathogens and ImmunityCase Western Reserve University | 34 % | 24 | 3.60 | 29 | Open access, fee unknown |
| International Journal of MycobacteriologyElsevier BV | 36 % | 102 | 1.26 | 40 | Open access, fee unknown |
| Infection and ChemotherapyJin Publishing & Printing Co. | 28 % | 83 | 2.62 | 51 | 200 USD |
| The Indian Journal of Medical ResearchMedknow | 21 % | 134 | 4.25 | 94 | Open access, fee unknown |
| Biomedical and Biotechnology Research Journal (BBRJ)Medknow | 34 % | 89 | 1.45 | 26 | Open access, fee unknown |
| EpidemiologiaMultidisciplinary Digital Publishing Institute | 28 % | 56 | 3.04 | 21 | 1 448 USD |
| Global Health & MedicinePublisher unknown | 31 % | 64 | 1.96 | 29 | Subscription |
| Tropical Medicine and HealthBioMed Central | 22 % | 116 | 3.27 | 60 | 2 990 USD |
| BMC Global and Public HealthPublisher unknown | 25 % | 46 | 4.48 | 20 | 2 490 USD |
| Journal of Infection PreventionSAGE Publishing | 44 % | 40 | 1.14 | 35 | Subscription; open access option 3 900 USD |
| Tropical Medicine & International HealthWiley | 25 % | 152 | 2.01 | 165 | Subscription; open access option 3 400 USD |
| AnaerobeElsevier BV | 22 % | 102 | 3.68 | 120 | Subscription; open access option 3 350 USD |
| Frontiers in Tropical DiseasesFrontiers Media | 25 % | 95 | 2.56 | 25 | 2 353 USD |
| LungSpringer Science+Business Media | 21 % | 90 | 4.50 | 92 | Subscription; open access option 4 290 USD |
| Canadian Journal of Infectious Diseases and Medical MicrobiologyPulsus Group | 26 % | 84 | 2.42 | 65 | 2 160 USD |
| ZoonosesCompuscript (Ireland) | 30 % | 36 | 2.79 | 16 | Open access, fee unknown |
| Journal de Mycologie MédicaleElsevier BV | 30 % | 71 | 1.82 | 55 | Subscription; open access option 3 250 USD |
| Antiviral TherapySAGE Publishing | 36 % | 24 | 2.24 | 103 | 2 800 USD |
| hLifeElsevier BV | 24 % | 34 | 5.64 | 19 | 2 300 USD |
| Infectious Disease Clinics of North AmericaElsevier BV | 24 % | 72 | 3.32 | 150 | Subscription; open access option 4 050 USD |
| Current HIV ResearchBentham Science Publishers | 40 % | 52 | 1.09 | 69 | Subscription |
| GERMSEuropean HIV/AIDS and Infectious Diseases Academy | 30 % | 49 | 2.18 | 30 | Subscription |
| Journal of Infection and ChemotherapyElsevier BV | 23 % | 279 | 1.73 | 86 | Subscription; open access option 2 650 USD |
| Public Health ActionInternational Union Against Tuberculosis and Lung Disease | 39 % | 44 | 1.24 | 35 | Open access, fee unknown |
| Pathogens and Global HealthTaylor & Francis | 24 % | 57 | 3.52 | 69 | Subscription |
| Antimicrobial Stewardship & Healthcare EpidemiologyCambridge University Press | 32 % | 464 | 0.69 | 25 | 2 719 USD |
| New Microbes and New InfectionsElsevier BV | 23 % | 169 | 1.88 | 60 | 2 770 USD |
| Oxford Open ImmunologyOxford University Press | 32 % | 13 | 4.98 | 21 | 2 331 USD |
| Osong Public Health and Research PerspectivesElsevier BV | 26 % | 54 | 2.70 | 53 | Open access, fee unknown |
| RetrovirologyBioMed Central | 24 % | 25 | 5.00 | 118 | 2 890 USD |
| Journal of AIDS and HIV TreatmentScientific Archives LLC | 50 % | 10 | 1.56 | 8 | Subscription |
| Journal of the Pediatric Infectious Diseases SocietyOxford University Press | 22 % | 205 | 1.62 | 69 | Subscription; open access option 4 752 USD |
| Sexual HealthCSIRO Publishing | 26 % | 95 | 1.54 | 67 | Subscription |
| Infection Disease & HealthElsevier BV | 37 % | 96 | 0.74 | 29 | Subscription; open access option 2 250 USD |
| AIDS Research and TreatmentHindawi Publishing Corporation | 47 % | 14 | 1.34 | 46 | 1 000 USD |
| Current Fungal Infection ReportsSpringer Science+Business Media | 33 % | 22 | 2.05 | 42 | Subscription; open access option 3 890 USD |
| Tuberculosis and lung diseasesNEW TERRA Publishing House | 39 % | 86 | 0.70 | 25 | Open access, fee unknown |
| Infectious Microbes & DiseasesWolters Kluwer | 33 % | 30 | 1.65 | 18 | 1 800 USD |
| Archives of Internal Medicine ResearchPublisher unknown | 27 % | 36 | 2.37 | 10 | Open access, fee unknown |
| Tropical Diseases Travel Medicine and VaccinesBioMed Central | 22 % | 31 | 4.20 | 34 | 2 790 USD |
| Revista Española de QuimioterapiaSociedad Española de Quimioterapia | 24 % | 118 | 1.50 | 28 | Open access, fee unknown |
| Indian Journal of Medical MicrobiologyElsevier BV | 22 % | 259 | 1.20 | 81 | 2 210 USD |
| Journal of Public Health in AfricaAOSIS | 26 % | 122 | 1.19 | 33 | 431 USD |
| Aids ReviewsPublisher unknown | 45 % | 25 | 0.85 | 22 | Subscription |
| Current Clinical Microbiology ReportsSpringer Science+Business Media | 21 % | 22 | 6.29 | 42 | Subscription; open access option 4 790 USD |
| Pan African Medical JournalAfrican Field Epidemiology Network | 21 % | 602 | 0.96 | 73 | 180 USD |
| International Journal of Vaccine Theory Practice and ResearchPublisher unknown | 38 % | 16 | 1.52 | 11 | Open access, fee unknown |
| Journal of Infectious Diseases and EpidemiologyPublisher unknown | 41 % | 39 | 0.78 | 17 | Open access, fee unknown |
| Exploratory Research and Hypothesis in MedicinePublisher unknown | 29 % | 36 | 1.69 | 13 | Open access, fee unknown |
| Southern African Journal of Infectious DiseasesTaylor & Francis | 37 % | 40 | 0.93 | 22 | 597 USD |
| Current Infectious Disease ReportsSpringer Science+Business Media | 25 % | 26 | 2.90 | 81 | Subscription; open access option 4 390 USD |
| BioMedPublisher unknown | 25 % | 32 | 2.35 | 13 | 1 207 USD |
| African Health SciencesMakerere University | 22 % | 245 | 1.09 | 79 | Open access, fee unknown |
| Archives of Clinical and Biomedical ResearchPublisher unknown | 38 % | 71 | 0.63 | 14 | Subscription |
| Clinical Infection in PracticeElsevier BV | 34 % | 89 | 0.62 | 14 | 2 000 USD |
| Medical Mycology Case ReportsElsevier BV | 28 % | 57 | 1.15 | 32 | 650 USD |
| Frontiers in TuberculosisFrontiers Media | 36 % | 10 | 2.00 | 6 | 2 353 USD |
146 more journals publish in Infectious Diseases; the analysis of your paper considers all of them.
Which of these fit your paper?
Paste your title and abstract and get these journals ranked for your work, with the closest published articles as evidence. Free, and your abstract is never stored.
Journals in CWTS Journal Indicators Core or the Directory of Open Access Journals that published at least 20 articles in the last five years, mostly in English. "In this field" is the share of a journal's articles that OpenAlex classifies in Infectious Diseases. Citation rate is OpenAlex's two-year mean citedness, an open measure similar to the journal impact factor. Fees are taken from OpenAlex and DOAJ and can be out of date: always check the journal's own website before you submit.